首页 > 最新文献

Harvard Review of Psychiatry最新文献

英文 中文
Applications of Speech Analysis in Psychiatry: Erratum. 语音分析在精神病学中的应用:勘误。
IF 2.5 4区 医学 Q2 PSYCHIATRY Pub Date : 2023-03-01 DOI: 10.1097/HRP.0000000000000357
{"title":"Applications of Speech Analysis in Psychiatry: Erratum.","authors":"","doi":"10.1097/HRP.0000000000000357","DOIUrl":"10.1097/HRP.0000000000000357","url":null,"abstract":"","PeriodicalId":12915,"journal":{"name":"Harvard Review of Psychiatry","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9131287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges of Agitation in Dementia: A Plea for Early Discussion. 痴呆症中躁动的挑战:早期讨论的请求。
IF 3.8 4区 医学 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1097/HRP.0000000000000352
Leah G Richler, Mariko Shimizu, Hsiang Huang, Rachel Kester
Abstract Behavioral and psychological symptoms of dementia (BPSD) occur frequently among people with dementia and are known precipitants for placement in care facilities. Despite the social, financial, and psychological impact on dementia care, education and discussions on BPSD have not been routinely included in advance care planning (ACP). As a result, families can face great challenges in making complex medical decisions when their loved ones are admitted to the geriatric psychiatric inpatient unit with refractory BPSD. We present the case of an 83-year-old gentleman with BPSD to illustrate universal struggles in dementia care experienced by many families, which could have been alleviated by education and discussions around BPSD earlier in the patient’s dementia course. A literature search did not yield any articles that mention discussions of BPSD in ACP. The lack of literature referencing BPSD in ACP supports our clinical experiences with the case and highlights the need for improvement in current dementia care. We propose a guideline for providers to facilitate conversations around BPSD as an integral part of ACP, including discussions of four key points related to the progressive nature of dementia, the commonality of BPSD, the lack of FDA-approved treatment for BPSD, and the difficulty in balancing agitation and sedation to allow safe placement. We firmly believe it is important to start discussion on BPSD as part of ACP as early as possible. Early education and discussion will help to facilitate meaningful care decisions as patients and families navigate the challenges associated with this progressive disease.
痴呆症的行为和心理症状(BPSD)在痴呆症患者中经常发生,并且是已知的安置在护理机构的前兆。尽管社会、经济和心理对痴呆症护理有影响,但关于BPSD的教育和讨论并没有常规地包括在预先护理计划(ACP)中。因此,当他们的亲人因难治性BPSD入住老年精神科住院病房时,家庭在做出复杂的医疗决定时可能面临巨大的挑战。我们提出了一个83岁的BPSD患者的案例,以说明许多家庭在痴呆症护理中所经历的普遍斗争,这些斗争本可以通过在患者痴呆症病程早期就BPSD进行教育和讨论来缓解。文献检索没有发现任何提及ACP中BPSD讨论的文章。缺乏ACP中BPSD的文献支持了我们的临床经验,并强调了当前痴呆护理的改进需求。作为ACP的一个组成部分,我们提出了一个指导方针,以促进围绕BPSD的对话,包括讨论与痴呆的进行性、BPSD的共性、缺乏fda批准的BPSD治疗以及平衡躁动和镇静以确保安全放置的困难相关的四个关键点。我们坚信,重要的是尽早开始讨论BPSD作为ACP的一部分。早期教育和讨论将有助于促进有意义的护理决策,因为患者和家属应对与这种进行性疾病相关的挑战。
{"title":"Challenges of Agitation in Dementia: A Plea for Early Discussion.","authors":"Leah G Richler, Mariko Shimizu, Hsiang Huang, Rachel Kester","doi":"10.1097/HRP.0000000000000352","DOIUrl":"https://doi.org/10.1097/HRP.0000000000000352","url":null,"abstract":"Abstract Behavioral and psychological symptoms of dementia (BPSD) occur frequently among people with dementia and are known precipitants for placement in care facilities. Despite the social, financial, and psychological impact on dementia care, education and discussions on BPSD have not been routinely included in advance care planning (ACP). As a result, families can face great challenges in making complex medical decisions when their loved ones are admitted to the geriatric psychiatric inpatient unit with refractory BPSD. We present the case of an 83-year-old gentleman with BPSD to illustrate universal struggles in dementia care experienced by many families, which could have been alleviated by education and discussions around BPSD earlier in the patient’s dementia course. A literature search did not yield any articles that mention discussions of BPSD in ACP. The lack of literature referencing BPSD in ACP supports our clinical experiences with the case and highlights the need for improvement in current dementia care. We propose a guideline for providers to facilitate conversations around BPSD as an integral part of ACP, including discussions of four key points related to the progressive nature of dementia, the commonality of BPSD, the lack of FDA-approved treatment for BPSD, and the difficulty in balancing agitation and sedation to allow safe placement. We firmly believe it is important to start discussion on BPSD as part of ACP as early as possible. Early education and discussion will help to facilitate meaningful care decisions as patients and families navigate the challenges associated with this progressive disease.","PeriodicalId":12915,"journal":{"name":"Harvard Review of Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f0/bc/hrp-31-22.PMC9855747.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10730331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Implications of the Neurosteroid Allopregnanolone in Reproductive Depression. 神经类固醇异孕酮治疗生殖抑郁症的临床意义。
IF 3.8 4区 医学 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1097/HRP.0000000000000354
Leah C Susser

Abstract: Certain women develop depression with fluctuations in hormone levels whereas other women do not; this hormonally driven depression has been termed reproductive depression. The pathophysiology of reproductive depression differs from that of major depressive disorder, and this distinction has important clinical-including treatment-implications. Recent advances have revealed that the neurosteroid, allopregnanolone, plays a central role in reproductive depression. Appreciation of allopregnanolone's role in reproductive depression aids in selecting targeted treatments and in predicting symptom worsening during subsequent reproductive stages, and it can be used to reduce risk of relapse. This knowledge is also guiding the development of new pharmacologic treatments for reproductive depression.

摘要:某些女性会随着激素水平的波动而患上抑郁症,而另一些女性则不会;这种激素驱动的抑郁症被称为生殖抑郁症。生殖抑郁症的病理生理不同于重度抑郁症,这种区别具有重要的临床意义,包括治疗意义。最近的进展表明,神经类固醇异孕酮在生殖抑郁症中起着核心作用。了解异孕酮在生殖抑郁中的作用有助于选择有针对性的治疗方法,预测随后生殖阶段症状恶化,并可用于降低复发风险。这一知识也指导了生殖抑郁症新药物治疗的发展。
{"title":"Clinical Implications of the Neurosteroid Allopregnanolone in Reproductive Depression.","authors":"Leah C Susser","doi":"10.1097/HRP.0000000000000354","DOIUrl":"https://doi.org/10.1097/HRP.0000000000000354","url":null,"abstract":"<p><strong>Abstract: </strong>Certain women develop depression with fluctuations in hormone levels whereas other women do not; this hormonally driven depression has been termed reproductive depression. The pathophysiology of reproductive depression differs from that of major depressive disorder, and this distinction has important clinical-including treatment-implications. Recent advances have revealed that the neurosteroid, allopregnanolone, plays a central role in reproductive depression. Appreciation of allopregnanolone's role in reproductive depression aids in selecting targeted treatments and in predicting symptom worsening during subsequent reproductive stages, and it can be used to reduce risk of relapse. This knowledge is also guiding the development of new pharmacologic treatments for reproductive depression.</p>","PeriodicalId":12915,"journal":{"name":"Harvard Review of Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10730334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Clinical and Ethical Dilemmas in the Involuntary Treatment of Anorexia Nervosa. 神经性厌食症非自愿治疗的临床与伦理困境。
IF 3.8 4区 医学 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1097/HRP.0000000000000355
Jenny Tumba, Megan Smith, Kyle E Rodenbach

Learning objectives: After completing this activity, practitioners will be better able to:• Discuss the growing body literature emphasizing moderation and harm-reduction in patients with severe and enduring anorexia nervosa (SE-AN)• Outline and discuss the legal, ethical, and medical challenges inpatient providers face when treating patients with SE-AN.

Abstract: Patients with severe and enduring anorexia nervosa (SE-AN) present numerous clinical and ethical challenges for the hospital psychiatrist. Patients typically come to the hospital in a state of severe medical compromise. Common difficulties in the period of acute medical stabilization include assessment of decision-making capacity and the right to decline treatment, as well as legally complex decisions pertaining to administering artificial nutrition over the patient's objection. Following acute medical stabilization, the psychiatric consultant must decide whether psychiatric hospitalization for continued treatment is indicated, and if so, whether involuntary hospitalization is indicated. The standard of care in these situations is unclear. Pragmatic issues such as lack of appropriate facilities for specialized treatment are common. If involuntary hospitalization is not approved or not pursued, there may be difficulty in determining whether, when, and how to involve palliative care consultants to guide further management. These cases are complex and largely reside in a medico-legal and ethical gray area. This article discusses the difficulties associated with these cases and supports a growing body of literature emphasizing moderation and harm-reduction in patients with SE-AN. Physician-assisted dying (PAD) is also discussed.

学习目标:完成本活动后,从业者将能够更好地:•讨论越来越多的强调严重和持久神经性厌食症(SE-AN)患者适度和减少伤害的身体文献•概述并讨论住院医生在治疗SE-AN患者时面临的法律、伦理和医学挑战。摘要:重度和持续性神经性厌食症(SE-AN)患者对医院精神科医生提出了许多临床和伦理挑战。患者通常是在病情严重的情况下来到医院的。急性医疗稳定期间的常见困难包括评估决策能力和拒绝治疗的权利,以及不顾病人反对给予人工营养的复杂法律决定。在急性医疗稳定之后,精神科咨询师必须决定是否需要继续住院治疗,如果需要,是否需要非自愿住院治疗。在这些情况下的护理标准尚不清楚。缺乏适当的专门治疗设施等实际问题是常见的。如果不批准或不实行非自愿住院,可能难以确定是否、何时以及如何让姑息治疗顾问指导进一步的管理。这些案件很复杂,大部分处于医学法律和伦理的灰色地带。本文讨论了与这些病例相关的困难,并支持越来越多的文献强调SE-AN患者的适度和减少伤害。医生协助死亡(PAD)也进行了讨论。
{"title":"Clinical and Ethical Dilemmas in the Involuntary Treatment of Anorexia Nervosa.","authors":"Jenny Tumba,&nbsp;Megan Smith,&nbsp;Kyle E Rodenbach","doi":"10.1097/HRP.0000000000000355","DOIUrl":"https://doi.org/10.1097/HRP.0000000000000355","url":null,"abstract":"<p><strong>Learning objectives: </strong>After completing this activity, practitioners will be better able to:• Discuss the growing body literature emphasizing moderation and harm-reduction in patients with severe and enduring anorexia nervosa (SE-AN)• Outline and discuss the legal, ethical, and medical challenges inpatient providers face when treating patients with SE-AN.</p><p><strong>Abstract: </strong>Patients with severe and enduring anorexia nervosa (SE-AN) present numerous clinical and ethical challenges for the hospital psychiatrist. Patients typically come to the hospital in a state of severe medical compromise. Common difficulties in the period of acute medical stabilization include assessment of decision-making capacity and the right to decline treatment, as well as legally complex decisions pertaining to administering artificial nutrition over the patient's objection. Following acute medical stabilization, the psychiatric consultant must decide whether psychiatric hospitalization for continued treatment is indicated, and if so, whether involuntary hospitalization is indicated. The standard of care in these situations is unclear. Pragmatic issues such as lack of appropriate facilities for specialized treatment are common. If involuntary hospitalization is not approved or not pursued, there may be difficulty in determining whether, when, and how to involve palliative care consultants to guide further management. These cases are complex and largely reside in a medico-legal and ethical gray area. This article discusses the difficulties associated with these cases and supports a growing body of literature emphasizing moderation and harm-reduction in patients with SE-AN. Physician-assisted dying (PAD) is also discussed.</p>","PeriodicalId":12915,"journal":{"name":"Harvard Review of Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10730330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Applications of Speech Analysis in Psychiatry. 语音分析在精神病学中的应用。
IF 2.5 4区 医学 Q2 PSYCHIATRY Pub Date : 2023-01-01 DOI: 10.1097/HRP.0000000000000356
Katerina Dikaios, Sheri Rempel, Sri Harsha Dumpala, Sageev Oore, Michael Kiefte, Rudolf Uher

Abstract: The need for objective measurement in psychiatry has stimulated interest in alternative indicators of the presence and severity of illness. Speech may offer a source of information that bridges the subjective and objective in the assessment of mental disorders. We systematically reviewed the literature for articles exploring speech analysis for psychiatric applications. The utility of speech analysis depends on how accurately speech features represent clinical symptoms within and across disorders. We identified four domains of the application of speech analysis in the literature: diagnostic classification, assessment of illness severity, prediction of onset of illness, and prognosis and treatment outcomes. We discuss the findings in each of these domains, with a focus on how types of speech features characterize different aspects of psychopathology. Models that bring together multiple speech features can distinguish speakers with psychiatric disorders from healthy controls with high accuracy. Differentiating between types of mental disorders and symptom dimensions are more complex problems that expose the transdiagnostic nature of speech features. Convergent progress in speech research and computer sciences opens avenues for implementing speech analysis to enhance objectivity of assessment in clinical practice. Application of speech analysis will need to address issues of ethics and equity, including the potential to perpetuate discriminatory bias through models that learn from clinical assessment data. Methods that mitigate bias are available and should play a key role in the implementation of speech analysis.

摘要:精神病学对客观测量的需求激发了人们对疾病存在和严重程度的替代指标的兴趣。在评估精神障碍时,言语可能是连接主观和客观的信息来源。我们对文献进行了系统性的梳理,以查找探讨语音分析在精神科应用的文章。言语分析的实用性取决于言语特征在疾病内部和疾病之间如何准确地反映临床症状。我们在文献中确定了语音分析应用的四个领域:诊断分类、疾病严重程度评估、发病预测以及预后和治疗结果。我们讨论了每个领域的研究结果,重点是语音特征类型如何描述精神病理学的不同方面。汇集多种语音特征的模型可以高精度地区分患有精神障碍的说话者和健康对照者。区分精神障碍类型和症状维度是更为复杂的问题,暴露了语音特征的跨诊断性质。语音研究和计算机科学的共同进步为在临床实践中实施语音分析以提高评估的客观性开辟了道路。语音分析的应用需要解决伦理和公平问题,包括通过从临床评估数据中学习的模型可能造成的歧视性偏见。减轻偏见的方法是可用的,并应在语音分析的实施中发挥关键作用。
{"title":"Applications of Speech Analysis in Psychiatry.","authors":"Katerina Dikaios, Sheri Rempel, Sri Harsha Dumpala, Sageev Oore, Michael Kiefte, Rudolf Uher","doi":"10.1097/HRP.0000000000000356","DOIUrl":"10.1097/HRP.0000000000000356","url":null,"abstract":"<p><strong>Abstract: </strong>The need for objective measurement in psychiatry has stimulated interest in alternative indicators of the presence and severity of illness. Speech may offer a source of information that bridges the subjective and objective in the assessment of mental disorders. We systematically reviewed the literature for articles exploring speech analysis for psychiatric applications. The utility of speech analysis depends on how accurately speech features represent clinical symptoms within and across disorders. We identified four domains of the application of speech analysis in the literature: diagnostic classification, assessment of illness severity, prediction of onset of illness, and prognosis and treatment outcomes. We discuss the findings in each of these domains, with a focus on how types of speech features characterize different aspects of psychopathology. Models that bring together multiple speech features can distinguish speakers with psychiatric disorders from healthy controls with high accuracy. Differentiating between types of mental disorders and symptom dimensions are more complex problems that expose the transdiagnostic nature of speech features. Convergent progress in speech research and computer sciences opens avenues for implementing speech analysis to enhance objectivity of assessment in clinical practice. Application of speech analysis will need to address issues of ethics and equity, including the potential to perpetuate discriminatory bias through models that learn from clinical assessment data. Methods that mitigate bias are available and should play a key role in the implementation of speech analysis.</p>","PeriodicalId":12915,"journal":{"name":"Harvard Review of Psychiatry","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9498436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychotic Misdiagnosis of Racially Minoritized Patients: A Case-Based Ethics, Equity, and Educational Exploration. 少数族裔患者的精神病误诊:基于个案的伦理、公平与教育探索。
IF 3.8 4区 医学 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1097/HRP.0000000000000353
Anita M Jegarl, Oluwole Jegede, Jessica Isom, Nicole Ciarleglio, Carmen Black

Abstract: The overdiagnosis and misdiagnosis of racially minoritized groups as having a primary psychotic disorder is one of psychiatry's longest-standing inequities born of real-time clinician racial bias. Evidence suggests that providers assign a diagnosis of schizophrenia and/or schizoaffective disorder according to race more than any other demographic variable, and this inequity persists even in the absence of differences in clinician symptom ratings. This case report describes the journey of one young Black woman through her racialized misdiagnosis of schizophrenia and the process by which interdisciplinary, health equity-minded providers across the spectrum of medical education and practice joined together to provide a culturally informed, systematic rediagnosis of major depressive disorder and post-traumatic stress disorder. Expert discussion is provided by three Black academic psychiatrists with expertise in social justice and health equity. We provide an evidence-based exploration of mechanisms of clinician racial bias and detail how the psychosis misdiagnosis of racially minoritized groups fails medical ethics and perpetuates iatrogenic harm to patients who truly need help with primary mood, trauma, and substance use disorders.

摘要:对少数族裔群体的过度诊断和误诊为原发性精神障碍是精神病学长期存在的不公平现象之一,这种不公平源于临床医生的种族偏见。有证据表明,提供者根据种族而不是其他人口统计学变量来分配精神分裂症和/或分裂情感性障碍的诊断,即使在临床医生症状评分没有差异的情况下,这种不平等仍然存在。本病例报告描述了一名年轻黑人妇女的精神分裂症种族化误诊的历程,以及跨医学教育和实践领域的跨学科、注重健康公平的提供者联合起来,为重度抑郁症和创伤后应激障碍提供文化信息、系统的重新诊断的过程。专家讨论由三名在社会正义和健康公平方面具有专长的黑人学术精神科医生提供。我们对临床医生种族偏见的机制进行了基于证据的探索,并详细说明了少数种族群体的精神病误诊是如何违背医学伦理的,并使那些真正需要帮助的原发性情绪、创伤和物质使用障碍患者的医源性伤害持续存在。
{"title":"Psychotic Misdiagnosis of Racially Minoritized Patients: A Case-Based Ethics, Equity, and Educational Exploration.","authors":"Anita M Jegarl,&nbsp;Oluwole Jegede,&nbsp;Jessica Isom,&nbsp;Nicole Ciarleglio,&nbsp;Carmen Black","doi":"10.1097/HRP.0000000000000353","DOIUrl":"https://doi.org/10.1097/HRP.0000000000000353","url":null,"abstract":"<p><strong>Abstract: </strong>The overdiagnosis and misdiagnosis of racially minoritized groups as having a primary psychotic disorder is one of psychiatry's longest-standing inequities born of real-time clinician racial bias. Evidence suggests that providers assign a diagnosis of schizophrenia and/or schizoaffective disorder according to race more than any other demographic variable, and this inequity persists even in the absence of differences in clinician symptom ratings. This case report describes the journey of one young Black woman through her racialized misdiagnosis of schizophrenia and the process by which interdisciplinary, health equity-minded providers across the spectrum of medical education and practice joined together to provide a culturally informed, systematic rediagnosis of major depressive disorder and post-traumatic stress disorder. Expert discussion is provided by three Black academic psychiatrists with expertise in social justice and health equity. We provide an evidence-based exploration of mechanisms of clinician racial bias and detail how the psychosis misdiagnosis of racially minoritized groups fails medical ethics and perpetuates iatrogenic harm to patients who truly need help with primary mood, trauma, and substance use disorders.</p>","PeriodicalId":12915,"journal":{"name":"Harvard Review of Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10730332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Unremitting Suicidality in Borderline Personality Disorder: A Single Case Study and Discussion of Technology in Clinical Care. 边缘型人格障碍患者持续自杀:个案研究及临床护理技术探讨。
IF 3.8 4区 医学 Q1 Medicine Pub Date : 2022-11-01 DOI: 10.1097/HRP.0000000000000351
Lois W Choi-Kain, Grace E Murray, Mark J Goldblatt, Chelsey R Wilks, Ipsit V Vahia, Daniel D L Coppersmith, Gabrielle S Ilagan, Boyu Ren
CASE HISTORYAND TREATMENT This report presents the case of a young woman, “Jane.” The case is followed by commentary from three experts in suicidal or self-destructive behavior and the use of technology in clinical care. Jane is a college-aged female with a diagnosis of borderline personality disorder (BPD) and a history of repetitive self-harm, including head banging and cutting, as well as chronic, unremitting suicidal ideation. Jane had been in an intensive residential program for many months, and during this time she was stepped up to inpatient psychiatric hospitalization multiple times due to concerns about safety. Jane had a history of multiple suicide attempts while in outpatient, residential, and inpatient settings.Most of these attempts occurred on hospital units using methods like self-strangulation with available objects, self-suffocation, and self-starvation. Upon discharge from her last inpatient psychiatric admission, Jane was admitted to an intensive specialized residential program for adult women with borderline and other severe personality disorders. This unit integrates evidence-based treatments includingdialectical behavior therapy (DBT),mentalization based treatment (MBT), and good psychiatric management (GPM). The standard treatment protocol includes daily DBT diary cards, check-ins with the program’s 24-hour counselors,
{"title":"Unremitting Suicidality in Borderline Personality Disorder: A Single Case Study and Discussion of Technology in Clinical Care.","authors":"Lois W Choi-Kain,&nbsp;Grace E Murray,&nbsp;Mark J Goldblatt,&nbsp;Chelsey R Wilks,&nbsp;Ipsit V Vahia,&nbsp;Daniel D L Coppersmith,&nbsp;Gabrielle S Ilagan,&nbsp;Boyu Ren","doi":"10.1097/HRP.0000000000000351","DOIUrl":"https://doi.org/10.1097/HRP.0000000000000351","url":null,"abstract":"CASE HISTORYAND TREATMENT This report presents the case of a young woman, “Jane.” The case is followed by commentary from three experts in suicidal or self-destructive behavior and the use of technology in clinical care. Jane is a college-aged female with a diagnosis of borderline personality disorder (BPD) and a history of repetitive self-harm, including head banging and cutting, as well as chronic, unremitting suicidal ideation. Jane had been in an intensive residential program for many months, and during this time she was stepped up to inpatient psychiatric hospitalization multiple times due to concerns about safety. Jane had a history of multiple suicide attempts while in outpatient, residential, and inpatient settings.Most of these attempts occurred on hospital units using methods like self-strangulation with available objects, self-suffocation, and self-starvation. Upon discharge from her last inpatient psychiatric admission, Jane was admitted to an intensive specialized residential program for adult women with borderline and other severe personality disorders. This unit integrates evidence-based treatments includingdialectical behavior therapy (DBT),mentalization based treatment (MBT), and good psychiatric management (GPM). The standard treatment protocol includes daily DBT diary cards, check-ins with the program’s 24-hour counselors,","PeriodicalId":12915,"journal":{"name":"Harvard Review of Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1f/b0/hrp-30-350.PMC9770128.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10846269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methemoglobinemia in a Patent Presenting with an Undisclosed Intentional Overdose. 高铁血红蛋白血症的一项专利显示未公开的故意过量用药。
IF 3.8 4区 医学 Q1 Medicine Pub Date : 2022-11-01 DOI: 10.1097/HRP.0000000000000348
Claire L Gibson, Sarah B Abdallah, Natalie R Neumann, Hun Millard, Sarah Riley
{"title":"Methemoglobinemia in a Patent Presenting with an Undisclosed Intentional Overdose.","authors":"Claire L Gibson,&nbsp;Sarah B Abdallah,&nbsp;Natalie R Neumann,&nbsp;Hun Millard,&nbsp;Sarah Riley","doi":"10.1097/HRP.0000000000000348","DOIUrl":"https://doi.org/10.1097/HRP.0000000000000348","url":null,"abstract":"","PeriodicalId":12915,"journal":{"name":"Harvard Review of Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10553182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Structural and Functional Brain Alterations in Populations with Familial Risk for Depression: A Narrative Review. 具有家族性抑郁风险人群的大脑结构和功能改变:一项叙述性综述。
IF 3.8 4区 医学 Q1 Medicine Pub Date : 2022-11-01 DOI: 10.1097/HRP.0000000000000350
Birce Begum Burhanoglu, Ali Saffet Gonul

Learning objectives: After completing this activity, practitioners will be better able to:• Discuss the association between brain alterations and vulnerability or resilience to MDD in people with familial risk• Define how structural and functional brain alterations associated with vulnerability or resilience could lead to a better understanding of the pathophysiology of MDD.

Aim: Familial history is associated with an increased risk for major depressive disorder (MDD). Despite the increased risk, some members of the familial high-risk population remain healthy, that is, resilient. Defining the structural and functional brain alterations associated with vulnerability or resilience could lead to a better understanding of the pathophysiology of MDD. This study aimed to review the current literature and discuss the association between brain alterations and vulnerability or resilience to MDD in people with familial risk.

Methods: A literature search on MRI studies investigating structural and functional alterations in populations at familial risk for MDD was performed using the PubMed and SCOPUS databases. The search was conducted through June 13, 2022.

Results: We reviewed and summarized the data of 72 articles (25 structural MRI, 35 functional MRI, 10 resting-state fMRI, one structural/functional MRI combined, and one structural/functional/resting-state fMRI combined). These findings suggested that resilience in high-risk individuals is related to the amygdala structure, frontal lobe activity, and functional connectivity between the amygdala and multiple frontal regions.

Conclusion: Resilient and vulnerable individuals exhibit structural and functional differences in multiple frontal and limbic regions. However, further systematic longitudinal research incorporating environmental factors is required to validate the current findings.

学习目标:完成本活动后,从业者将能够更好地:•讨论具有家族性风险的人的大脑改变与易感性或抗抑郁能力之间的关系•定义与易感性或抗抑郁能力相关的大脑结构和功能改变如何能够更好地理解重度抑郁症的病理生理学。目的:家族史与重度抑郁症(MDD)风险增加有关。尽管风险增加,家族高危人群中的一些成员仍然健康,也就是说,有弹性。定义与脆弱性或恢复力相关的大脑结构和功能改变可以更好地理解重度抑郁症的病理生理学。本研究旨在回顾目前的文献,并讨论大脑改变与家族风险人群对重度抑郁症的易感性或恢复力之间的关系。方法:利用PubMed和SCOPUS数据库对MDD家族风险人群结构和功能改变的MRI研究进行文献检索。搜寻工作一直持续到2022年6月13日。结果:我们回顾和总结了72篇文献的资料(结构MRI 25篇,功能MRI 35篇,静息态fMRI 10篇,结构/功能MRI联合1篇,结构/功能/静息态fMRI联合1篇)。这些发现表明,高风险个体的恢复能力与杏仁核结构、额叶活动以及杏仁核和多个额叶区域之间的功能连接有关。结论:弹性个体和易感个体在额叶和边缘多区表现出结构和功能上的差异。然而,需要进一步纳入环境因素的系统纵向研究来验证当前的研究结果。
{"title":"Structural and Functional Brain Alterations in Populations with Familial Risk for Depression: A Narrative Review.","authors":"Birce Begum Burhanoglu,&nbsp;Ali Saffet Gonul","doi":"10.1097/HRP.0000000000000350","DOIUrl":"https://doi.org/10.1097/HRP.0000000000000350","url":null,"abstract":"<p><strong>Learning objectives: </strong>After completing this activity, practitioners will be better able to:• Discuss the association between brain alterations and vulnerability or resilience to MDD in people with familial risk• Define how structural and functional brain alterations associated with vulnerability or resilience could lead to a better understanding of the pathophysiology of MDD.</p><p><strong>Aim: </strong>Familial history is associated with an increased risk for major depressive disorder (MDD). Despite the increased risk, some members of the familial high-risk population remain healthy, that is, resilient. Defining the structural and functional brain alterations associated with vulnerability or resilience could lead to a better understanding of the pathophysiology of MDD. This study aimed to review the current literature and discuss the association between brain alterations and vulnerability or resilience to MDD in people with familial risk.</p><p><strong>Methods: </strong>A literature search on MRI studies investigating structural and functional alterations in populations at familial risk for MDD was performed using the PubMed and SCOPUS databases. The search was conducted through June 13, 2022.</p><p><strong>Results: </strong>We reviewed and summarized the data of 72 articles (25 structural MRI, 35 functional MRI, 10 resting-state fMRI, one structural/functional MRI combined, and one structural/functional/resting-state fMRI combined). These findings suggested that resilience in high-risk individuals is related to the amygdala structure, frontal lobe activity, and functional connectivity between the amygdala and multiple frontal regions.</p><p><strong>Conclusion: </strong>Resilient and vulnerable individuals exhibit structural and functional differences in multiple frontal and limbic regions. However, further systematic longitudinal research incorporating environmental factors is required to validate the current findings.</p>","PeriodicalId":12915,"journal":{"name":"Harvard Review of Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10553183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
(In)Equality and Beyond: Achieving Justice in Gender-Affirming Hormone Initiation. (三)平等及超越:在性别确认激素启动中实现公正。
IF 3.8 4区 医学 Q1 Medicine Pub Date : 2022-11-01 DOI: 10.1097/HRP.0000000000000349
Christina L Macenski, Alex S Keuroghlian, Christopher G AhnAllen, Genny Beemyn, Eli Erlick, Jules Gill-Peterson, Joanna Marie Harper, Rebeca Ramos, Daphna Stroumsa, Fernando J Benetti, John A Fromson

Abstract: The World Professional Association for Transgender Health (WPATH) is an international organization that aims to advocate for transgender and gender-diverse (TGD) people by promoting safe and effective ways to access and deliver healthcare to maximize psychological health and well-being. One way this is achieved is through the WPATH's published Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People, a set of guidelines for gender-affirming care that is based on the available science and expert consensus. In anticipation of the release of updated guidelines (Standards of Care Version 8) in 2022 the Radcliffe Institute for Advanced Study at Harvard University hosted an Exploratory Seminar in December 2021 that brought together experts from the United States, Mexico, and the United Kingdom to share knowledge across disciplines in order to propose revisions to the WPATH's updated guidelines. This article shares the workgroup's high-level consensus and recommendations.

摘要:世界跨性别健康专业协会(WPATH)是一个国际组织,旨在倡导跨性别和性别多样化(TGD)的人,通过促进安全有效的方式获得和提供医疗保健,以最大限度地提高心理健康和福祉。实现这一目标的一种方法是通过世界卫生适宜卫生组织发布的《变性人、跨性别者和性别不符合者健康护理标准》,这是一套基于现有科学和专家共识的性别确认护理指南。预计2022年将发布更新的指南(护理标准第8版),哈佛大学拉德克利夫高级研究所于2021年12月举办了一场探索性研讨会,汇集了来自美国、墨西哥和英国的专家,分享跨学科的知识,以提出对WPATH更新指南的修订建议。本文分享了工作组的高层共识和建议。
{"title":"(In)Equality and Beyond: Achieving Justice in Gender-Affirming Hormone Initiation.","authors":"Christina L Macenski,&nbsp;Alex S Keuroghlian,&nbsp;Christopher G AhnAllen,&nbsp;Genny Beemyn,&nbsp;Eli Erlick,&nbsp;Jules Gill-Peterson,&nbsp;Joanna Marie Harper,&nbsp;Rebeca Ramos,&nbsp;Daphna Stroumsa,&nbsp;Fernando J Benetti,&nbsp;John A Fromson","doi":"10.1097/HRP.0000000000000349","DOIUrl":"https://doi.org/10.1097/HRP.0000000000000349","url":null,"abstract":"<p><strong>Abstract: </strong>The World Professional Association for Transgender Health (WPATH) is an international organization that aims to advocate for transgender and gender-diverse (TGD) people by promoting safe and effective ways to access and deliver healthcare to maximize psychological health and well-being. One way this is achieved is through the WPATH's published Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People, a set of guidelines for gender-affirming care that is based on the available science and expert consensus. In anticipation of the release of updated guidelines (Standards of Care Version 8) in 2022 the Radcliffe Institute for Advanced Study at Harvard University hosted an Exploratory Seminar in December 2021 that brought together experts from the United States, Mexico, and the United Kingdom to share knowledge across disciplines in order to propose revisions to the WPATH's updated guidelines. This article shares the workgroup's high-level consensus and recommendations.</p>","PeriodicalId":12915,"journal":{"name":"Harvard Review of Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10553181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Harvard Review of Psychiatry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1